<p>Brookstone Capital Management 在最近向证券交易委员会的披露中表示，在第三季度将其在礼来公司的持股增加了 10.9%。该基金在季度内购买了 4,558 股后，持有该公司 46,325 股股票。Brookstone Capital Management 在礼来公司的持股在最近的报告期末价值为 35,346,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>行业轮动：2026 年的两个聪明资金动向</li>
</ul>
<p>其他一些对冲基金最近也增加或减少了在该公司的股份。财富保护顾问公司在第一季度购买了礼来公司的新股份，价值约为 27,000 美元。住友三井金融集团在第二季度购买了礼来公司的新股份，价值 27,000 美元。Evolution Wealth Management 在第二季度购买了礼来公司的新股份，价值约 29,000 美元。Steph &amp; Co.在第三季度将其在礼来公司的股份增加了 290.0%。Steph &amp; Co.现在持有该公司 39 股股票，价值 30,000 美元，此前在上个季度又购买了 29 股。最后，Financial Gravity Companies 在第二季度购买了礼来公司的新股份，价值 31,000 美元。机构投资者和对冲基金持有该公司 82.53% 的股票。</p>
<h2>礼来公司股票上涨 0.5%</h2>
<p>礼来公司（NYSE:LLY）周五开盘价为 1,077.06 美元。该公司的 50 日移动平均线为 981.27 美元，200 日移动平均线为 839.03 美元。礼来公司的 1 年最低价为 623.78 美元，1 年最高价为 1,111.99 美元。该股票的市值为 1.02 万亿美元，市盈率为 52.69，市盈增长比率为 1.09，贝塔值为 0.37。该公司的债务与股本比率为 1.71，速动比率为 1.24，流动比率为 1.55。</p>
<ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）最近在 10 月 30 日发布了其财报。该公司报告季度每股收益为 7.02 美元，超出分析师一致预期的 6.42 美元，超出幅度为 0.60 美元。礼来公司的净利润率为 30.99%，股本回报率为 109.52%。该公司在本季度的收入为 176 亿美元，而分析师预期为 160.9 亿美元。去年同期，该公司的每股收益为 1.18 美元。本季度的收入较去年同期增长了 53.9%。礼来公司已将其 2025 财年的每股收益指导设定为 23.000-23.700。股票分析师预计礼来公司今年的每股收益将达到 23.48。</p>
<h2>礼来公司增加股息</h2>
<p>该公司最近还披露了季度股息，将于 3 月 10 日支付。记录在案的投资者将在 2 月 13 日获得 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。除息日期为 2 月 13 日。这代表着每年 6.92 美元的股息，收益率为 0.6%。礼来公司的股息支付比率目前为 29.35%。</p>
<h2>分析师评级变动</h2>
<ul>
<li>辉瑞加大对减肥药的投资</li>
</ul>
<p>LLY 已成为几份研究分析师报告的主题。桑福德·C·伯恩斯坦在 12 月 19 日的研究报告中重申了对礼来公司股票的 “跑赢大盘” 评级。摩根大通在 11 月 18 日的研究报告中将礼来公司的目标价从 1,050.00 美元上调至 1,150.00 美元，并给予该公司 “增持” 评级。Truist Financial 在 11 月 19 日的报告中将礼来公司的目标价从 1,038.00 美元上调至 1,182.00 美元，并给予该公司 “买入” 评级。Loop Capital 在 11 月 10 日的研究报告中对礼来公司的目标价设定为 950.00 美元。最后，大和美国在 12 月 16 日的研究报告中将礼来公司的评级从 “持有” 上调至 “强烈买入”。四位研究分析师对该股票给予了 “强烈买入” 评级，十七位给予了 “买入” 评级，五位给予了 “持有” 评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标价为 1,155.36 美元。</p>
<p><strong>阅读我们关于 LLY 的最新报告</strong></p>
<h2>礼来公司公司简介</h2>
<p>（免费报告）</p>
<p>礼来公司（NYSE: LLY）是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来在北美、欧洲、亚洲及其他地区维持运营和商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
<h2>另请参阅</h2>
<ul>
<li>五只我们更看好的股票比礼来公司更好</li>
<li>在 1 月 1 日之前将 1,000 美元投入这只股票【不是 NVDA】</li>
<li>将你的 “死钱” 转变为每月 306 美元以上（从这个月开始）</li>
<li>华盛顿为战争做准备</li>
<li>奇怪的水晶金属性能超过硅高达 100 倍</li>
<li>从奇怪的新 “AI 燃料” 中获得 33,000% 的增长</li>
</ul>
<p><strong>想看看其他对冲基金持有的 LLY 吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前立即购买……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Brookstone Capital Management 在第三季度增持了礼来公司的股份，增幅为 10.9%，目前持有 46,325 股，市值为 3535 万美元。礼来的股票开盘价为 1077.06 美元，市值为 1.02 万亿美元。该公司报告第三季度每股收益为 7.02 美元，超出预期，并将股息提高至 1.73 美元。分析师对该股票给予了 “适度买入” 的一致评级</p>

<p>Brookstone Capital Management increased its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 10.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 46,325 shares of the company's stock after purchasing an additional 4,558 shares during the quarter. Brookstone Capital Management's holdings in Eli Lilly and Company were worth $35,346,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Brookstone Capital Management 在最近向证券交易委员会的披露中表示，在第三季度将其在礼来公司的持股增加了 10.9%。该基金在季度内购买了 4,558 股后，持有该公司 46,325 股股票。Brookstone Capital Management 在礼来公司的持股在最近的报告期末价值为 35,346,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Sector Rotation: 2 Smart Money Moves for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>行业轮动：2026 年的两个聪明资金动向</li>
</ul>
</div><p>A number of other hedge funds have also recently added to or reduced their stakes in the company. Wealth Preservation Advisors LLC bought a new stake in shares of Eli Lilly and Company in the 1st quarter worth approximately $27,000. Sumitomo Mitsui Financial Group Inc. bought a new stake in Eli Lilly and Company in the second quarter valued at $27,000. Evolution Wealth Management Inc. purchased a new stake in Eli Lilly and Company in the second quarter worth about $29,000. Steph &amp; Co. lifted its stake in shares of Eli Lilly and Company by 290.0% in the third quarter. Steph &amp; Co. now owns 39 shares of the company's stock worth $30,000 after buying an additional 29 shares in the last quarter. Finally, Financial Gravity Companies Inc. bought a new stake in shares of Eli Lilly and Company in the second quarter worth $31,000. Institutional investors and hedge funds own 82.53% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也增加或减少了在该公司的股份。财富保护顾问公司在第一季度购买了礼来公司的新股份，价值约为 27,000 美元。住友三井金融集团在第二季度购买了礼来公司的新股份，价值 27,000 美元。Evolution Wealth Management 在第二季度购买了礼来公司的新股份，价值约 29,000 美元。Steph &amp; Co.在第三季度将其在礼来公司的股份增加了 290.0%。Steph &amp; Co.现在持有该公司 39 股股票，价值 30,000 美元，此前在上个季度又购买了 29 股。最后，Financial Gravity Companies 在第二季度购买了礼来公司的新股份，价值 31,000 美元。机构投资者和对冲基金持有该公司 82.53% 的股票。</p>
</div><h2>Eli Lilly and Company Stock Up 0.5%</h2>
<div class="lb-trans"><h2>礼来公司股票上涨 0.5%</h2>
</div><p>Shares of NYSE:LLY opened at $1,077.06 on Friday. The company's fifty day moving average is $981.27 and its two-hundred day moving average is $839.03. Eli Lilly and Company has a 1-year low of $623.78 and a 1-year high of $1,111.99. The stock has a market capitalization of $1.02 trillion, a price-to-earnings ratio of 52.69, a price-to-earnings-growth ratio of 1.09 and a beta of 0.37. The company has a debt-to-equity ratio of 1.71, a quick ratio of 1.24 and a current ratio of 1.55.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY）周五开盘价为 1,077.06 美元。该公司的 50 日移动平均线为 981.27 美元，200 日移动平均线为 839.03 美元。礼来公司的 1 年最低价为 623.78 美元，1 年最高价为 1,111.99 美元。该股票的市值为 1.02 万亿美元，市盈率为 52.69，市盈增长比率为 1.09，贝塔值为 0.37。该公司的债务与股本比率为 1.71，速动比率为 1.24，流动比率为 1.55。</p>
</div><ul>
<li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li>
</ul>
<div class="lb-trans"><ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last issued its earnings results on Thursday, October 30th. The company reported $7.02 earnings per share for the quarter, topping analysts' consensus estimates of $6.42 by $0.60. Eli Lilly and Company had a net margin of 30.99% and a return on equity of 109.52%. The firm had revenue of $17.60 billion during the quarter, compared to analysts' expectations of $16.09 billion. During the same period last year, the firm posted $1.18 earnings per share. The firm's revenue for the quarter was up 53.9% compared to the same quarter last year. Eli Lilly and Company has set its FY 2025 guidance at 23.000-23.700 EPS. Equities analysts anticipate that Eli Lilly and Company will post 23.48 EPS for the current year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最近在 10 月 30 日发布了其财报。该公司报告季度每股收益为 7.02 美元，超出分析师一致预期的 6.42 美元，超出幅度为 0.60 美元。礼来公司的净利润率为 30.99%，股本回报率为 109.52%。该公司在本季度的收入为 176 亿美元，而分析师预期为 160.9 亿美元。去年同期，该公司的每股收益为 1.18 美元。本季度的收入较去年同期增长了 53.9%。礼来公司已将其 2025 财年的每股收益指导设定为 23.000-23.700。股票分析师预计礼来公司今年的每股收益将达到 23.48。</p>
</div><h2>Eli Lilly and Company Increases Dividend</h2>
<div class="lb-trans"><h2>礼来公司增加股息</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Friday, February 13th will be given a $1.73 dividend. This is a boost from Eli Lilly and Company's previous quarterly dividend of $1.50. The ex-dividend date is Friday, February 13th. This represents a $6.92 annualized dividend and a yield of 0.6%. Eli Lilly and Company's dividend payout ratio is presently 29.35%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，将于 3 月 10 日支付。记录在案的投资者将在 2 月 13 日获得 1.73 美元的股息。这比礼来公司之前的季度股息 1.50 美元有所增加。除息日期为 2 月 13 日。这代表着每年 6.92 美元的股息，收益率为 0.6%。礼来公司的股息支付比率目前为 29.35%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>Pfizer Adds to Its Big Bet on Weight Loss Drugs</li>
</ul>
<div class="lb-trans"><ul>
<li>辉瑞加大对减肥药的投资</li>
</ul>
</div><p>LLY has been the subject of several research analyst reports. Sanford C. Bernstein reaffirmed an &#34;outperform&#34; rating on shares of Eli Lilly and Company in a research note on Friday, December 19th. JPMorgan Chase &amp; Co. lifted their price objective on shares of Eli Lilly and Company from $1,050.00 to $1,150.00 and gave the company an &#34;overweight&#34; rating in a research note on Tuesday, November 18th. Truist Financial increased their price objective on shares of Eli Lilly and Company from $1,038.00 to $1,182.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, November 19th. Loop Capital set a $950.00 price target on shares of Eli Lilly and Company in a research report on Monday, November 10th. Finally, Daiwa America upgraded Eli Lilly and Company from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Tuesday, December 16th. Four research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $1,155.36.</p>
<div class="lb-trans"><p>LLY 已成为几份研究分析师报告的主题。桑福德·C·伯恩斯坦在 12 月 19 日的研究报告中重申了对礼来公司股票的 “跑赢大盘” 评级。摩根大通在 11 月 18 日的研究报告中将礼来公司的目标价从 1,050.00 美元上调至 1,150.00 美元，并给予该公司 “增持” 评级。Truist Financial 在 11 月 19 日的报告中将礼来公司的目标价从 1,038.00 美元上调至 1,182.00 美元，并给予该公司 “买入” 评级。Loop Capital 在 11 月 10 日的研究报告中对礼来公司的目标价设定为 950.00 美元。最后，大和美国在 12 月 16 日的研究报告中将礼来公司的评级从 “持有” 上调至 “强烈买入”。四位研究分析师对该股票给予了 “强烈买入” 评级，十七位给予了 “买入” 评级，五位给予了 “持有” 评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标价为 1,155.36 美元。</p>
</div><p><strong>Read Our Latest Report on LLY</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 LLY 的最新报告</strong></p>
</div><h2>Eli Lilly and Company Company Profile</h2>
<div class="lb-trans"><h2>礼来公司公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company NYSE: LLY is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.</p>
<div class="lb-trans"><p>礼来公司（NYSE: LLY）是一家成立于 1876 年的全球制药公司，总部位于印第安纳州印第安纳波利斯。该公司研究、开发、生产和商业化广泛的药物和疗法，服务于全球患者。礼来在北美、欧洲、亚洲及其他地区维持运营和商业存在，服务于发达市场和新兴市场。近年来，该公司由总裁兼首席执行官 David A.领导。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li>
<li>Washington prepares for war</li>
<li>Strange Crystal Metal Outperforms Silicon Up to 100X</li>
<li>33,000% boom from weird new “AI Fuel?”</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比礼来公司更好</li>
<li>在 1 月 1 日之前将 1,000 美元投入这只股票【不是 NVDA】</li>
<li>将你的 “死钱” 转变为每月 306 美元以上（从这个月开始）</li>
<li>华盛顿为战争做准备</li>
<li>奇怪的水晶金属性能超过硅高达 100 倍</li>
<li>从奇怪的新 “AI 燃料” 中获得 33,000% 的增长</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding LLY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Company (NYSE:LLY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 LLY 吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前立即购买……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Brookstone Capital Management 持有价值 3535 万美元的 Eli Lilly 公司股票 $LLY